Strongly agree. Our incident log is 90% solvent handling and 10% sharps. Zero biological.

Anyone else notice that the reproducibility argument always ends with "we need better metadata" and never with "we need to fund replication"?

Because metadata is cheap to advocate for and replication is not.

Biosafety take: none of this is a problem at BSL-1 with non-pathogenic chassis. The failure mode in community labs is almost never the organism, it is the chemical waste.

The cost curve here is real but the pilot scale is 500 L. Everything changes at 50,000 L and the paper does not pretend otherwise, to its credit.

It is in there — line 14, the $22 board. The expensive part historically was the Peltier driver and that is what got cheap.